Scienture is a pharmaceutical company that markets and develops prescription medicines for heart and nervous system diseases. SCNX reports earnings on Wed, Nov 11, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 23 | Maxim Group | Maintained | Buy |
Whale Options Flow
90DNo whale options trades in SCNX in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SCNX is in one of them and how their past SCNX trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered SCNX in an article yet. Here's the latest on the wider market.
About Scienture Holdings
Scienture is a specialty pharmaceutical company based in Commack, New York. It markets and develops prescription medicines for cardiovascular and central nervous system conditions, serving patients in the United States. Its marketed products include an oral liquid form of losartan for high blood pressure and a nasal spray naloxone product for opioid overdose. The company also has a pipeline of candidate treatments for conditions such as migraine, blood clots, and pain.
- Headquarters
- Commack, NY